Shaw and Partners have upgraded their target price to circa $10.50, I will go with them, topped up today at $8.91
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025